DAFNE: authors' response to electronic letters from 5th October to 22nd October 2002

Study Group DAFNE; S Heller; J Speight; S Amiel; Clare Bradley; P James; S Roberts

DAFNE: authors' response to electronic letters from 5th October to 22nd October 2002

Study Group DAFNE, S Heller , J Speight, S Amiel, Clare Bradley, P James, S Roberts

Health Psychology Research Unit

Research output: Contribution to journal › Letter › peer-review

53 Downloads (Pure)

Abstract

The rapid responses received following the publication of the DAFNE trial reflect the controversy surrounding the current inadequate management of Type 1 diabetes. [1] While it is true that the approach is not novel (Ullman, 5th Oct; Black,6th Oct; Reed, 9th Oct; Chaufan, 12th October, Cohen, 22nd Oct), it is new to the UK. The biomedical benefits of this intensified approach had been known for some time in parts of Europe [2,3] but is was unclear whether these could be transferred to a British health care setting. furthermore, the impact on quality of life was unknown, as psychological outcomes were not measured in the early German work.

Original language	English
Journal	British Medical Journal
Publication status	Published - 29 Oct 2002

Keywords

Type 1 diabetes
Health care
Quality of life

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

Full TextFinal published version, 17.9 KB

Cite this

@article{055d7b19d05c41d78df5dc8e80cf8abd,

title = "DAFNE: authors' response to electronic letters from 5th October to 22nd October 2002",

abstract = "The rapid responses received following the publication of the DAFNE trial reflect the controversy surrounding the current inadequate management of Type 1 diabetes. [1] While it is true that the approach is not novel (Ullman, 5th Oct; Black,6th Oct; Reed, 9th Oct; Chaufan, 12th October, Cohen, 22nd Oct), it is new to the UK. The biomedical benefits of this intensified approach had been known for some time in parts of Europe [2,3] but is was unclear whether these could be transferred to a British health care setting. furthermore, the impact on quality of life was unknown, as psychological outcomes were not measured in the early German work.",

keywords = "Type 1 diabetes, Health care, Quality of life",

author = "DAFNE, {Study Group} and S Heller and J Speight and S Amiel and Clare Bradley and P James and S Roberts",

year = "2002",

month = oct,

day = "29",

language = "English",

journal = "British Medical Journal",

issn = "0959-535X",

}

TY - JOUR

T1 - DAFNE: authors' response to electronic letters from 5th October to 22nd October 2002

AU - DAFNE, Study Group

AU - Heller , S

AU - Speight, J

AU - Amiel, S

AU - Bradley, Clare

AU - James, P

AU - Roberts, S

PY - 2002/10/29

Y1 - 2002/10/29

N2 - The rapid responses received following the publication of the DAFNE trial reflect the controversy surrounding the current inadequate management of Type 1 diabetes. [1] While it is true that the approach is not novel (Ullman, 5th Oct; Black,6th Oct; Reed, 9th Oct; Chaufan, 12th October, Cohen, 22nd Oct), it is new to the UK. The biomedical benefits of this intensified approach had been known for some time in parts of Europe [2,3] but is was unclear whether these could be transferred to a British health care setting. furthermore, the impact on quality of life was unknown, as psychological outcomes were not measured in the early German work.

AB - The rapid responses received following the publication of the DAFNE trial reflect the controversy surrounding the current inadequate management of Type 1 diabetes. [1] While it is true that the approach is not novel (Ullman, 5th Oct; Black,6th Oct; Reed, 9th Oct; Chaufan, 12th October, Cohen, 22nd Oct), it is new to the UK. The biomedical benefits of this intensified approach had been known for some time in parts of Europe [2,3] but is was unclear whether these could be transferred to a British health care setting. furthermore, the impact on quality of life was unknown, as psychological outcomes were not measured in the early German work.

KW - Type 1 diabetes

KW - Health care

KW - Quality of life

M3 - Letter

SN - 0959-535X

JO - British Medical Journal

JF - British Medical Journal

ER -